New York City returns to all remote learning, sparking outrage from parents Fox News correspondent Laura Ingle reports on ‘Fox News @ Night with Shannon
Read more
Home »
Improvements in lung cancer care
Cancer care is constantly evolving. And nowhere is that more true than with lung cancer. “In just the last few years, lung cancer care has
Read more
Experts Optimistic Cancer Research Will Get a Boost in the Biden Presidency
Advocates say they’re optimistic about the future of cancer research during the incoming Biden administration. They describe President-elect Joe Biden and Vice President-elect Kamala Harris
Read more
Every month delayed in cancer treatment can raise risk of death by around 10%
People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% higher risk of dying—a risk that
Read more
Study examines health literacy and shared decision-making in prostate cancer screening
New research examines the dynamics between men’s health literacy, their discussions with their doctors, and their decisions on whether to get tested for prostate-specific antigen
Read more
Eating ‘lion’s mane’ may reduce risk of heart disease and offer protection against cancer
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. When it
Read more
Taking Lipid-Lowering Meds Tied to Lower Risk for Cancer Death
THURSDAY, Oct. 22, 2020 — For women with breast cancer, colorectal cancer, or melanoma, adherence to lipid-lowering medications (LLM) is inversely linked to cancer-specific mortality,
Read more
Merck Presents Three-Year Survival Data for Keytruda (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With Keytruda in Advanced Non‑Small Cell Lung Cancer
KENILWORTH, N.J.–(BUSINESS WIRE) October 16, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from two
Read more
BMD Testing Rates Low in Men Initiating ADT for Prostate Cancer
TUESDAY, Oct. 13, 2020 — The rate of bone mineral density (BMD) testing is low among men with prostate cancer initiating androgen deprivation therapy (ADT),
Read more
Study finds cancer mutations accumulate in distinct regions based on structure of genome and mutation
A new study from researchers at The University of Texas MD Anderson Cancer Center has discovered that mutations found in cancers do not accumulate randomly,
Read more